Abstract
THE unequivocal establishment of the somatic mutation theory of cancer requires the demonstration that all carcinogenic agents can induce some viable alterations in the genic DNA. Earlier studies of the mutagenicity of chemical carcinogens (reviewed in ref. 1) yielded positive results for alkylating and nitroso compounds, but not for hydrocarbons and aromatic amines. On the whole, however, these studies were restricted to point mutations: either at few loci in microorganisms or as exemplified by recessive lethals in Drosophila. The possibility therefore remained that mutability with some agents might have occurred at uninvestigated loci, or involved mutational mechanisms unrelated to those resulting in point mutations. Another complication was that carcinogenicity with certain compounds seemed to require previous metabolic activation2, which might not occur in some of the genetic test systems used. An extensive investigation was therefore undertaken of the mutational spectra of a wide range of carcinogens—or their active metabolites in Drosophila—and most of the results have recently been published already3. The only genetic aberrations induced by all the compounds tested were the dominant visible mutations resulting in the “Minute” phenotype. These are deletion mutations, hemizygously and homozygously lethal, which have often been located in the heterochromatin4—6. This suggested that the significant genetic change in carcinogenesis might well be the elimination of specific heterochromatic gene loci, and experiments were designed to test this possibility.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Burdette, W. J., Cancer Res., 15, 201 (1955).
Miller, E. C., and Miller, J. A., Pharmacol., Rev., 18, 805 (1966).
Fahmy, O. G., and Fahmy, M. J., Cancer Res. (in the press).
Hannah, A., in Advances in Genetics, 4, 87 (Academic Press, New York and London, 1951).
Fahmy, O. G., and Fahmy, M. J., Genetics, 52, 861 (1965).
Fahmy, O. G., and Fahmy, M. J., Genetics, 54, 1123 (1966).
Timofeeff-Ressovsky, N. W., Z. Indukt. Abstamm. Vererblehre., 65, 279 (1933).
Timofeeff-Ressovsky, N. W., and Delbrück, M., Z. Indukt. Abstamm. Vererblehre., 71, 322 (1936).
Fahmy, O. G., and Fahmy, M. J., Genetics, 44, 1149 (1959).
Ritossa, F. M., Atwood, K. C., and Spiegelman, S., Genetics, 54, 663 (1966).
Ritossa, F. M., Atwood, K. C., and Spiegelman, S., Genetics, 54, 819 (1966).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
FAHMY, O., FAHMY, M. Specific Genetic Deletions by a Carcinogenic Hydrocarbon in Drosophila. Nature 224, 1328–1329 (1969). https://doi.org/10.1038/2241328a0
Received:
Issue date:
DOI: https://doi.org/10.1038/2241328a0


